CUSIP: G70021111
Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / *W EXP 10/01/202
-
Total 13F shares
-
4,027,096
-
Share change
-
+3,209,596
-
Total reported value
-
$1,836,000
-
Price per share
-
$0.45
-
Number of holders
-
14
-
Value change
-
+$1,453,000
-
Number of buys
-
12
Quarterly Holders Quick Answers
What is CUSIP G70021111?
CUSIP G70021111 identifies PEPLW - PEPPERLIME HEALTH ACQUSTN CO - *W EXP 10/01/202 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G70021111:
Institutional Holders of PEPPERLIME HEALTH ACQUSTN CO - *W EXP 10/01/202 (PEPLW) as of Q4 2021
As of 31 Dec 2021,
PEPPERLIME HEALTH ACQUSTN CO - *W EXP 10/01/202 (PEPLW) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,027,096 shares.
The largest 10 holders included
RIVERNORTH CAPITAL MANAGEMENT, LLC, Empery Asset Management, LP, Polar Asset Management Partners Inc., Shaolin Capital Management LLC, Altium Capital Management LP, Saba Capital Management, L.P., HIGHBRIDGE CAPITAL MANAGEMENT LLC, UBS OCONNOR LLC, COWEN AND COMPANY, LLC, and WOLVERINE ASSET MANAGEMENT LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.